Havencrest Backs Offor Health in Majority Recapitalization

Havencrest Capital Partners has completed a majority recapitalization of Offor Health, a vertically integrated physical therapy platform that's built a network of more than 70 clinics across Florida and Texas. The deal keeps founder and CEO Chris Offor in place while bringing in new capital to accelerate a roll-up strategy that's already delivered steady expansion in two of the country's fastest-growing healthcare markets.

Financial terms weren't disclosed, but the transaction represents Havencrest's latest move into healthcare services — a sector the lower mid-market firm has targeted aggressively as consolidation pressure mounts on independent operators. For Offor, who launched the business and remains the largest individual shareholder post-deal, the partnership provides both liquidity and a growth engine to compete against larger, better-capitalized platforms.

The physical therapy sector has become a magnet for private equity in recent years as reimbursement pressures, regulatory complexity, and labor costs make it harder for single-clinic operators to survive. Platforms that can centralize billing, credentialing, HR, and compliance — while still maintaining local clinic autonomy — have proven resilient. Offor Health's model fits that template: corporate back-office support with decentralized clinical operations run by licensed therapists who retain day-to-day control.

What makes this deal more interesting than a standard platform recap is the geography. Florida and Texas aren't just high-growth states — they're also both experiencing rapid population aging, rising sports participation rates among younger demographics, and booming demand for orthopedic and musculoskeletal care. Offor Health has concentrated its footprint in suburban growth corridors where those trends converge.

Chris Offor founded the business with a clear thesis: that orthopedic physical therapy could be delivered better and more efficiently through a vertically integrated model that combined outpatient clinics with ancillary services like imaging, durable medical equipment, and wellness programs. The platform now operates more than 70 locations, primarily clustered in metro areas around Orlando, Tampa, Miami, Houston, and Dallas.

Unlike some PE-backed roll-ups that grow through rapid-fire M&A and aggressive integration timelines, Offor Health has taken a more measured approach. The company has added clinics steadily — both through acquisitions of existing practices and selective de novo builds — while maintaining a focus on clinical quality and patient outcomes. That's kept payor relationships strong and referral networks intact, two things that tend to erode when platforms grow too fast.

The company's vertically integrated model is a differentiator. Most outpatient PT platforms focus exclusively on therapy services. Offor Health has built out complementary offerings — diagnostic imaging, DME, and post-rehab wellness programs — that let it capture a larger share of the patient's care journey. That's not just a revenue play; it also improves continuity of care and makes the platform stickier with referring physicians who value one-stop convenience.

Havencrest's thesis appears to be that Offor Health has built the foundation correctly and is now ready to accelerate. The platform has proven the model works, established strong unit economics, and built a repeatable playbook for integrating new clinics. The question now is how fast it can scale without sacrificing what's made it successful.

Havencrest Capital Partners, based in Charlotte, North Carolina, has been an active investor in healthcare services for the better part of a decade. The firm targets lower mid-market companies — typically those with $5 million to $25 million in EBITDA — and focuses on sectors where fragmentation creates consolidation opportunities. Physical therapy checks every box. According to IBISWorld, the U.S. physical therapy industry generates roughly $40 billion in annual revenue but remains highly fragmented, with the top 50 operators controlling less than 30% of the market.

That fragmentation is both opportunity and challenge. On one hand, there are thousands of acquisition targets — small, independent practices run by therapists who are approaching retirement or burned out by administrative complexity. On the other, integration is hard. PT practices are built on local referral relationships, therapist retention, and clinical reputation — all things that can evaporate if a new owner mishandles the transition.

Havencrest's bet is that Offor Health has figured out the integration playbook. The platform has acquired dozens of practices over the past several years and maintained strong retention rates among both therapists and patients. That's not a given. Many PE-backed PT roll-ups have struggled with therapist turnover and referral erosion post-acquisition, particularly when they've imposed aggressive productivity targets or centralized decision-making too quickly.

The firm's prior healthcare services investments include home health, urgent care, and specialty physician practices — all sectors where the same dynamics apply. Build a scalable back-office, maintain clinical autonomy, grow through disciplined M&A, and avoid the temptation to squeeze margins too hard too fast.

Physical therapy has become one of the most active subsectors in healthcare services M&A. Private equity firms have backed dozens of platforms over the past five years, and several have reached significant scale. ATI Physical Therapy, one of the largest platforms, went public via SPAC in 2021 before filing for bankruptcy in 2023 — a cautionary tale about the risks of over-leveraging in a reimbursement-sensitive business. Others, like Upstream Rehabilitation and Confluent Health, have continued to grow steadily under PE ownership.

The appeal is straightforward: recurring revenue, predictable payor mix, non-cyclical demand, and a massive fragmented market. The risks are equally clear: reimbursement pressure from Medicare and commercial payors, labor costs driven by therapist shortages, and integration complexity that can destroy value if mismanaged.

What separates winners from losers in this space is operational discipline. Platforms that can drive same-store growth — not just top-line revenue through M&A — tend to perform better. That means improving patient throughput, optimizing payor mix, reducing no-show rates, and keeping therapists productive without burning them out. It also means avoiding the trap of paying up for acquisitions that don't improve unit economics.

Offor Health's focus on Florida and Texas is notable. Both states are seeing rapid population growth, particularly among older adults and active younger demographics — two cohorts with high demand for PT services. Florida added more than 700,000 residents between 2020 and 2023, while Texas added over 1.5 million, according to Census data. That demographic tailwind makes the market more forgiving for platforms that can capture market share.

The biggest structural challenge facing PT platforms is reimbursement. Medicare rates for outpatient therapy services have been under pressure for years, and commercial payors have followed suit. The shift toward value-based care and bundled payments has also created uncertainty, particularly for platforms that rely heavily on fee-for-service volume.

For Chris Offor, the transaction delivers liquidity while preserving his role and equity stake. That's the ideal outcome for a founder who's built real enterprise value but needs institutional capital to reach the next stage of growth. Majority recaps of this type typically involve the founder rolling a significant percentage of their equity into the new structure — often 30% to 50% — which keeps incentives aligned and signals confidence in the platform's trajectory.

The deal also suggests Offor Health was likely receiving inbound interest from other buyers or financial sponsors. Founders don't typically pursue recaps unless they're either responding to acquisition interest they want to decline or proactively seeking capital to fend off competitive pressure. In this case, the decision to partner with Havencrest rather than sell outright indicates Offor believes there's meaningful upside left to capture.

For Havencrest, the investment fits squarely within its strategy: acquire a founder-led, lower mid-market platform with a proven model, strong unit economics, and a clear M&A pipeline. The firm will likely push for faster growth — both through acquisitions and organic expansion — while providing the back-office infrastructure and capital access to support it.

One thing to watch is how aggressively the platform pursues M&A over the next 12 to 24 months. Havencrest will want to show momentum, which typically means closing several deals per year. The risk is that rapid M&A can strain integration capacity and dilute the culture that's kept therapists and patients loyal. The platforms that have succeeded in this space have grown deliberately, not recklessly.

The other thing to watch is how the platform navigates reimbursement trends. If Medicare or major commercial payors cut rates meaningfully, platforms that rely on volume-driven revenue models will face margin compression. Diversifying into ancillary services — imaging, DME, wellness — is one hedge. Shifting toward higher-margin specialties like hand therapy or pelvic health is another. Offor Health has already built out some of those capabilities, which puts it in a better position than pure-play therapy platforms.

Offor Health is now squarely in competition with larger, better-capitalized national platforms like Upstream and Confluent. Those platforms have scale advantages in payor negotiations, recruiting, and technology investments. What Offor Health has — and must protect — is local market density and operational agility. Being the dominant player in a metro area matters more than having a national footprint. Dense clusters of clinics allow for shared marketing, centralized scheduling, and better therapist utilization.

The platform's ability to stay nimble will be tested. National consolidators often struggle with bureaucracy and slow decision-making as they grow. If Offor Health can maintain the responsiveness and culture of a smaller organization while leveraging Havencrest's capital and expertise, it has a real shot at outcompeting larger rivals in its core markets.

The immediate priority post-close will be deploying capital into new acquisitions. Florida and Texas both have deep benches of independent PT practices ripe for consolidation. Many are owned by therapists in their 50s and 60s who lack succession plans and are open to selling if the terms are right and clinical autonomy is preserved.

Offor Health will also likely pursue selective de novo builds in underserved markets within its existing geographies. Opening new clinics from scratch takes longer but avoids goodwill and integration risk. It also allows the platform to design the clinic from the ground up — location, layout, staffing model, payor mix — rather than inheriting someone else's decisions.

Another area to watch is technology investment. PT platforms that have invested in patient engagement tools, telehealth capabilities, and data analytics have seen better retention and outcomes. Havencrest will likely push for upgrades in those areas, particularly if they can drive same-store revenue growth without adding headcount.

The partnership announcement mentioned plans to expand the platform's footprint, but didn't specify whether that means new states or deeper penetration in Florida and Texas. Given the demographic tailwinds in both markets, the smarter move is probably to double down on density before expanding geographically. Entering new states means new payor contracts, new regulatory environments, and new referral networks — all of which take time and capital to establish.

The success of this recap will ultimately hinge on whether Offor Health can keep its therapists happy and productive as it scales. Physical therapy is a people business, and therapists have options. If they feel micromanaged, overworked, or disconnected from leadership, they'll leave — and they'll take patients and referral relationships with them.

Platforms that have succeeded in this space have invested heavily in therapist development, career pathing, and retention programs. That means continuing education stipends, leadership opportunities, and compensation structures that reward outcomes, not just volume. It also means resisting the temptation to impose rigid productivity quotas that burn people out.

This transaction is a signal that lower mid-market healthcare services platforms remain attractive to private equity, even as broader M&A activity has slowed. The deal also highlights a trend: founders are increasingly opting for recaps over outright sales when they believe there's meaningful growth left and they want to retain control.

For other PT platform founders considering their options, the Offor Health-Havencrest partnership offers a useful case study. It shows that it's possible to take liquidity off the table, bring in institutional capital, and maintain operational control — provided you've built something valuable and sustainable.

For PE firms, the deal reinforces the playbook that works in healthcare services: find a founder-led platform with strong unit economics, a repeatable model, and a fragmented market. Provide capital and operational support, but don't over-engineer the integration. Let the founder run the business, and focus on enabling faster, smarter growth.

The physical therapy sector isn't going away, and neither is the consolidation wave. But the platforms that will win over the next five years aren't the ones that grow the fastest — they're the ones that grow the smartest.

While specific financial terms weren't disclosed, industry benchmarks for lower mid-market PT platform recaps typically fall in the 6x to 8x EBITDA range, depending on growth rate, payor mix, and geographic concentration. Platforms with strong same-store growth and diversified revenue streams command the higher end of that range.

Offor Health's 70+ clinic footprint puts it in the middle tier of PT platforms — larger than most regional independents, but smaller than the national consolidators. That's actually an advantage. It's big enough to have built scalable infrastructure, but small enough to remain operationally agile and culturally cohesive.

The Florida and Texas markets are both growing faster than the national average. Florida's population aged 65+ is expected to grow by 25% by 2030, while Texas is seeing outsized growth among active adults aged 35-54 — both demographics with high PT utilization rates. That demographic tailwind gives Offor Health a margin of safety that platforms in slower-growth markets don't have.

One metric that will be worth tracking post-close is same-store revenue growth. If Offor Health can drive 5% to 8% organic growth annually while adding 10 to 15 clinics per year, the platform will be in a strong position for a secondary transaction in three to five years — either to a larger PE firm or a strategic buyer.

The biggest risk for Offor Health isn't competition or reimbursement cuts — it's growing so fast that it loses the things that made it successful in the first place. Culture, clinical quality, and local market relationships are fragile. They don't scale automatically. They require intentional investment and constant vigilance.

Havencrest's track record suggests the firm understands this. Its prior healthcare services investments have generally followed a measured growth trajectory, prioritizing retention and integration quality over rapid M&A volume. If that discipline holds, Offor Health has a real shot at becoming a tier-one platform.

But the pressure will be there. Havencrest will have a five- to seven-year hold period and will need to show meaningful value creation to generate strong returns for its LPs. That typically means doubling or tripling EBITDA during the hold — which requires both M&A and margin improvement. The temptation to push too hard will be real.

The smartest move? Grow deliberately in markets they already dominate. Add clinics that improve density, not just clinic count. Invest in therapist development and retention. Resist the urge to squeeze margins. And stay focused on the long game — because in healthcare services, reputation and relationships are the real moat, and they take years to build but only months to destroy.